Pure Financial Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.1M | Buy |
58,997
+1,861
| +3% | +$215K | 0.1% | 93 |
|
|
2025
Q4 | $6.01M | Buy |
57,136
+2,840
| +5% | +$267K | 0.09% | 100 |
|
|
2025
Q3 | $4.56M | Sell |
54,296
-388
| -0.7% | -$32K | 0.07% | 110 |
|
|
2025
Q2 | $4.33M | Buy |
54,684
+30,910
| +130% | +$2.46M | 0.08% | 108 |
|
|
2025
Q1 | $2.13M | Buy |
23,774
+1,186
| +5% | +$111K | 0.04% | 125 |
|
|
2024
Q4 | $2.25M | Buy |
22,588
+1,517
| +7% | +$156K | 0.05% | 111 |
|
|
2024
Q3 | $2.39M | Sell |
21,071
-5,239
| -20% | -$622K | 0.06% | 107 |
|
|
2024
Q2 | $3.26M | Sell |
26,310
-50
| -0.2% | -$6.44K | 0.09% | 93 |
|
|
2024
Q1 | $3.48M | Buy |
26,360
+459
| +2% | +$56.6K | 0.11% | 88 |
|
|
2023
Q4 | $2.82M | Buy |
25,901
+2,556
| +11% | +$265K | 0.1% | 92 |
|
|
2023
Q3 | $2.4M | Buy |
23,345
+1,415
| +6% | +$153K | 0.1% | 91 |
|
|
2023
Q2 | $2.53M | Sell |
21,930
-58
| -0.3% | -$6.58K | 0.11% | 86 |
|
|
2023
Q1 | $2.34M | Buy |
21,988
+566
| +3% | +$61.1K | 0.11% | 86 |
|
|
2022
Q4 | $2.38M | Buy |
21,422
+43
| +0.2% | +$4.39K | 0.12% | 82 |
|
|
2022
Q3 | $1.84M | Buy |
21,379
+85
| +0.4% | +$7.59K | 0.11% | 85 |
|
|
2022
Q2 | $1.94M | Buy |
21,294
+673
| +3% | +$59.7K | 0.12% | 84 |
|
|
2022
Q1 | $1.69M | Buy |
20,621
+82
| +0.4% | +$6.46K | 0.08% | 87 |
|
|
2021
Q4 | $1.57M | Buy |
20,539
+704
| +4% | +$56.1K | 0.08% | 84 |
|
|
2021
Q3 | $1.49M | Buy |
19,835
+44
| +0.2% | +$3.35K | 0.11% | 83 |
|
|
2021
Q2 | $1.54M | Sell |
19,791
-950
| -5% | -$70.7K | 0.13% | 85 |
|
|
2021
Q1 | $1.53M | Buy |
20,741
+154
| +0.7% | +$11.4K | 0.15% | 75 |
|
|
2020
Q4 | $1.61M | Buy |
20,587
+119
| +0.6% | +$9.1K | 0.19% | 72 |
|
|
2020
Q3 | $1.62M | Buy |
20,468
+53
| +0.3% | +$4.15K | 0.24% | 62 |
|
|
2020
Q2 | $1.51M | Buy |
20,415
+142
| +0.7% | +$10.7K | 0.24% | 60 |
|
|
2020
Q1 | $1.49M | Sell |
20,273
-548
| -3% | -$43.1K | 0.25% | 54 |
|
|
2019
Q4 | $1.81M | Buy |
20,821
+321
| +2% | +$26.4K | 0.31% | 48 |
|
|
2019
Q3 | $1.65M | Buy |
20,500
+40
| +0.2% | +$3.21K | 0.3% | 50 |
|
|
2019
Q2 | $1.64M | Buy |
20,460
+393
| +2% | +$30.1K | 0.29% | 51 |
|
|
2019
Q1 | $1.59M | Sell |
20,067
-42
| -0.2% | -$3.14K | 0.3% | 49 |
|
|
2018
Q4 | $1.47M | Sell |
20,109
-1,108
| -5% | -$78.2K | 0.3% | 49 |
|
|
2018
Q3 | $1.44M | Buy |
+21,217
| New | +$1.35M | 0.31% | 47 |
|
|
2017
Q4 | – | Sell |
-20,483
| Closed | -$1.25M | – | 64 |
|
|
2017
Q3 | $1.25M | Sell |
20,483
-47
| -0.2% | -$2.85K | 0.32% | 39 |
|
|
2017
Q2 | $1.26M | Sell |
20,530
-167
| -0.8% | -$10.2K | 0.34% | 39 |
|
|
2017
Q1 | $1.25M | Buy |
20,697
+5
| +0% | +$303 | 0.36% | 34 |
|
|
2016
Q4 | $1.16M | Buy |
20,692
+170
| +0.8% | +$9.95K | 0.35% | 36 |
|
|
2016
Q3 | $1.22M | Buy |
20,522
+43
| +0.2% | +$2.52K | 0.39% | 33 |
|
|
2016
Q2 | $1.13M | Buy |
20,479
+256
| +1% | +$13.6K | 0.39% | 30 |
|
|
2016
Q1 | $1.04M | Buy |
20,223
+49
| +0.2% | +$2.4K | 0.37% | 32 |
|
|
2015
Q4 | $1.02M | Hold |
20,174
| – | – | 0.44% | 23 |
|
|
2015
Q3 | $951K | Sell |
20,174
-406
| -2% | -$21.6K | 0.45% | 24 |
|
|
2015
Q2 | $1.12M | Buy |
20,580
+5,917
| +40% | +$332K | 0.55% | 21 |
|
|
2015
Q1 | $804K | Buy |
14,663
+3,381
| +30% | +$191K | 0.27% | 26 |
|
|
2014
Q4 | $611K | Sell |
11,282
-9,206
| -45% | -$513K | 0.21% | 31 |
|
|
2014
Q3 | $1.16M | Sell |
20,488
-207
| -1% | -$11.6K | 0.43% | 21 |
|
|
2014
Q2 | $1.14M | Buy |
20,695
+207
| +1% | +$11.3K | 0.42% | 24 |
|
|
2014
Q1 | $1.09M | Buy |
20,488
+398
| +2% | +$20.6K | 0.44% | 23 |
|
|
2013
Q4 | $959K | Buy |
20,090
+283
| +1% | +$12.9K | 0.42% | 24 |
|
|
2013
Q3 | $900K | Buy |
19,807
+262
| +1% | +$12K | 0.43% | 23 |
|
|
2013
Q2 | $866K | Buy |
+19,545
| New | +$873K | 0.46% | 23 |
|
Other funds holding MRK
VCM
VPM
Pure Financial Advisors's MRK Position: Q1 2026 in Review
Pure Financial Advisors increased its Merck (MRK) stake by 3.3% in Q1 2026, buying an estimated $215K and bringing the position to 58,997 shares worth $7.1M. The position accounts for 0.1% of the portfolio, ranked #93.
Pure Financial Advisors first reported a position in MRK in Q2 2013 and has held it in 49 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Pure Financial Advisors held 58,997 shares of Merck worth $7.1M as of Q1 2026.
- Pure Financial Advisors bought 1,861 Merck shares in Q1 2026, an estimated $215K.
- Merck made up 0.1% of Pure Financial Advisors's portfolio in Q1 2026, its #93 holding.
- Pure Financial Advisors first reported a position in Merck in Q2 2013 and has held it in 49 quarters since.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Pure Financial Advisors's 13F filing for Q1 2026, filed 10 Apr 2026.